|
Paromomycin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
6 |
|
12 |
| No use |
1 |
|
12 |
|
|
Neomycin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
4 |
|
12 |
| No use |
0 |
|
12 |
|
|
Kanamycin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
4 |
|
12 |
| No use |
0 |
|
12 |
|
|
Tobramycin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
1 |
|
12 |
| No use |
2 |
|
12 |
|
|
Netilmicin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
0 |
|
12 |
| No use |
1 |
|
12 |
|
|
Gentamicin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
0 |
|
12 |
| No use |
0 |
|
12 |
|
|
Amikacin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
0 |
|
12 |
| No use |
0 |
|
12 |
|
|
Streptomycin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
2 |
|
12 |
| No use |
2 |
|
12 |
|
|
Amoxicillin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
3 |
|
12 |
| No use |
2 |
|
12 |
|
|
Tetracycline
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
11 |
|
12 |
| No use |
12 |
|
12 |
|
|
Chloramphenicol
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
1 |
|
12 |
| No use |
0 |
|
12 |
|
|
Nalidixic Acid
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
0 |
|
12 |
| No use |
0 |
|
12 |
|
|
Ciprofloxacin
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
0 |
|
12 |
| No use |
0 |
|
12 |
|
|
Sulfamethoxazole And Trimethoprim
/
|
Escherichia coli
|
| See: Table 2 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
0 |
|
12 |
| No use |
2 |
|
12 |
|
|
Kanamycin
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
2 |
|
10 |
| No use |
0 |
|
7 |
|
|
Gentamicin
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
1 |
|
10 |
| No use |
0 |
|
7 |
|
|
Streptomycin
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
2 |
|
10 |
| No use |
0 |
|
7 |
|
|
Ampicillin
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
0 |
|
10 |
| No use |
0 |
|
7 |
|
|
Tetracycline
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
10 |
|
10 |
| No use |
5 |
|
7 |
|
|
Chloramphenicol
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
4 |
|
10 |
| No use |
3 |
|
7 |
|
|
Sulfamethoxazole And Trimethoprim
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
2 |
|
10 |
| No use |
2 |
|
7 |
|
|
Vancomycin
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
0 |
|
10 |
| No use |
0 |
|
7 |
|
|
Teicoplanin
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
0 |
|
10 |
| No use |
0 |
|
7 |
|
|
Erythromycin
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
6 |
|
10 |
| No use |
4 |
|
7 |
|
|
Lincomycin
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
5 |
|
10 |
| No use |
4 |
|
7 |
|
|
Pristinamycin
/
|
Enterococcus faecium
|
| See: Table 4 |
AMR+ (n) |
AMR- (n) |
Total (n) |
| Paromomycin use |
1 |
|
10 |
| No use |
0 |
|
7 |
|